Status:
COMPLETED
Comparative Study Efficacy and Safety of of Activated Versus Non-Activated PRP
Lead Sponsor:
Al-Azhar University
Conditions:
Alopecia Areata
Eligibility:
All Genders
19-50 years
Phase:
EARLY_PHASE1
Brief Summary
This was comparative prospective study conducted on 40 subjects, diagnosed with alopecia areata of 40 the scalp, carried in a period from February 2020 and March 2021
Detailed Description
Alopecia areata is a common recurrent T cell-mediated autoimmune-induced non-scarring hair loss with not fully understood pathogenesis which affects nearly 2% of the general population during lifetime...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients diagnosed clinically and dermatoscopically as Alopecia areata of the scalp (uni- or 50 multilocularis).
- Age ranged between 18-50 years in both sex.
- Exclusion criteria:
- Previously treated patients.
- Pregnant women. 3 Patients with hematological disorders.
- 4\. Local infection at the site. 5. Patients with Hemoglobin \<10 g/dL and Platelet count \<105/µL. 6. Patients suffer from chronic and psychiatric diseases. 7.Age below 18years or age above 50 years ago.
Exclusion
Key Trial Info
Start Date :
February 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05251831
Start Date
February 1 2020
End Date
March 30 2021
Last Update
February 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Al-Azhar University in Cairo
Cairo, Egypt, 11311